Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609. Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608. Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608. Case and Commentary Feb 2007 Risks and Benefits of the New Medical Imaging Enterprise Judy Illes, PhD and Scott W. Atlas, MD Virtual Mentor. 2007;9(2):99-103. doi: 10.1001/virtualmentor.2007.9.2.ccas3-0702. Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709. Health Law Nov 2007 Referral Schemes at Imaging Centers Abigail Van Kempen Virtual Mentor. 2007;9(11):762-764. doi: 10.1001/virtualmentor.2007.9.11.hlaw1-0711. Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609.
Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608.
Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608.
Case and Commentary Feb 2007 Risks and Benefits of the New Medical Imaging Enterprise Judy Illes, PhD and Scott W. Atlas, MD Virtual Mentor. 2007;9(2):99-103. doi: 10.1001/virtualmentor.2007.9.2.ccas3-0702.
Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709.
Health Law Nov 2007 Referral Schemes at Imaging Centers Abigail Van Kempen Virtual Mentor. 2007;9(11):762-764. doi: 10.1001/virtualmentor.2007.9.11.hlaw1-0711.
Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706.